Mestrip is a new drug that has shown promising results in early clinical trials for treating cancer. Researchers gave Mestrip to 20 patients with late-stage cancer who had not responded well to other treatments. Half of the patients experienced a significant reduction in tumor size or slowing of cancer growth without severe side effects. Further research is still needed, but Mestrip could potentially provide a new treatment option for some cancer patients.